Localizing potentially active post-transcriptional regulations in the Ewing's sarcoma gene regulatory network

BackgroundA wide range of techniques is now available for analyzing regulatory networks. Nonetheless, most of these techniques fail to interpret large-scale transcriptional data at the post-translational level.ResultsWe address the question of using large-scale transcriptomic observation of a system perturbation to analyze a regulatory network which contained several types of interactions - transcriptional and post-translational. Our method consisted of post-processing the outputs of an open-source tool named BioQuali - an automatic constraint-based analysis mimicking biologist's local reasoning on a large scale. The post-processing relied on differences in the behavior of the transcriptional and post-translational levels in the network. As a case study, we analyzed a network representation of the genes and proteins controlled by an oncogene in the context of Ewing's sarcoma. The analysis allowed us to pinpoint active interactions specific to this cancer. We also identified the parts of the network which were incomplete and should be submitted for further investigation.ConclusionsThe proposed approach is effective for the qualitative analysis of cancer networks. It allows the integrative use of experimental data of various types in order to identify the specific information that should be considered a priority in the initial - and possibly very large - experimental dataset. Iteratively, new dataset can be introduced into the analysis to improve the network representation and make it more specific.

[1]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[2]  P. D. de Jong,et al.  Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints , 1992, Genes, chromosomes & cancer.

[3]  C. Denny,et al.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Triche,et al.  The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.

[5]  K. Tanaka,et al.  EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. , 1997, The Journal of clinical investigation.

[6]  M. Ladanyi,et al.  Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. , 1999, Cancer research.

[7]  K. Hahm Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein , 1999, Nature Genetics.

[8]  P. Sorensen,et al.  Delayed early embryonic lethality following disruption of the murine cyclin A2 gene , 1999, Nature Genetics.

[9]  Hidde de Jong,et al.  Genetic Network Analyzer: qualitative simulation of genetic regulatory networks , 2003, Bioinform..

[10]  D. Eisenberg,et al.  Use of Logic Relationships to Decipher Protein Network Organization , 2004, Science.

[11]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[12]  O. Delattre,et al.  EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3 , 2004, Molecular and Cellular Biology.

[13]  William S. Hlavacek,et al.  BioNetGen: software for rule-based modeling of signal transduction based on the interactions of molecular domains , 2004, Bioinform..

[14]  T. Triche,et al.  EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. , 2005, Cancer research.

[15]  M. Le Borgne,et al.  Topology and static response of interaction networks in molecular biology , 2006, Journal of The Royal Society Interface.

[16]  François Fages,et al.  BIOCHAM: an environment for modeling biological systems and formalizing experimental knowledge , 2006, Bioinform..

[17]  Alexander E. Kel,et al.  TRANSPATH®: an information resource for storing and visualizing signaling pathways and their pathological aberrations , 2005, Nucleic Acids Res..

[18]  T. Golub,et al.  Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. , 2006, Cancer cell.

[19]  T. Golub,et al.  Expression Profiling of EWS/FLI Identifies NKX2.2 as a Critical Target Gene in Ewing's Sarcoma (DOI: 10.1016/j.ccr.2006.04.004) , 2007 .

[20]  J. Collins,et al.  A network biology approach to prostate cancer , 2007, Molecular systems biology.

[21]  BMC Systems Biology , 2007 .

[22]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[23]  J. Baumbach,et al.  Linking Cytoscape and the corynebacterial reference database CoryneRegNet , 2008, BMC Genomics.

[24]  Natalie K. Wolf,et al.  IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells , 2008, PloS one.

[25]  F. Moreews,et al.  BioQuali Cytoscape plugin: analysing the global consistency of regulatory networks , 2009, BMC Genomics.

[26]  Jingtai Han Understanding biological functions through molecular networks , 2008, Cell Research.

[27]  K. Basso,et al.  A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas , 2008, Molecular systems biology.

[28]  M. L. Borgne Solving loosely coupled constraints , 2008 .

[29]  David P. Davis,et al.  Discovering cancer genes by integrating network and functional properties , 2009, BMC Medical Genomics.

[30]  J. Cerhan,et al.  Gene networks and microRNAs implicated in aggressive prostate cancer. , 2009, Cancer research.

[31]  E. Álava,et al.  Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target , 2009, British Journal of Cancer.

[32]  P. Meltzer,et al.  A Molecular Function Map of Ewing's Sarcoma , 2009, PloS one.

[33]  Carito Guziolowski,et al.  Designing Logical Rules to Model the Response of Biomolecular Networks with Complex Interactions: An Application to Cancer Modeling , 2011, IEEE/ACM Transactions on Computational Biology and Bioinformatics.